Eric A. Hughes

Insider Reports History

Entity
Individual
Location
C/O Teva, 5 Basel Street, P.O. Box 3190, Petach Tikva, Israel
Signature
/s/ Dov Bergwerk as attorney-in-fact for Eric A. Hughes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric A. Hughes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Executive Vice President, Global R&D and Chief Medical Officer Ordinary Shares 0 $0 $17.38 Aug 9, 2024 Direct
TEVA PHARMACEUTICAL INDUSTRIES LTD Executive Vice President, Global R&D and Chief Medical Officer Restricted Share Units 105K Aug 1, 2024 Direct
TEVA PHARMACEUTICAL INDUSTRIES LTD Executive Vice President, Global R&D and Chief Medical Officer Restricted Share Units 93K Mar 4, 2024 Direct

Insider Reports Filed by Eric A. Hughes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Aug 9, 2024 1 -$783K 4 Aug 13, 2024 Executive Vice President, Global R&D and Chief Medical Officer
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Aug 1, 2024 3 -$423K 4 Aug 5, 2024 Executive Vice President, Global R&D and Chief Medical Officer
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 3, 2024 4 -$107K 4 Mar 5, 2024 Executive Vice President, Global R&D and Chief Medical Officer
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Aug 1, 2023 3 -$438K 4 Aug 3, 2023 Executive Vice President, Global R&D and Chief Medical Officer
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 3, 2023 1 $0 4 Mar 7, 2023 Executive Vice President, Global R&D and Chief Medical Officer
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Aug 1, 2022 1 $0 4 Aug 3, 2022 Executive Vice President, Global R&D and Chief Medical Officer
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Aug 1, 2022 0 $0 3 Aug 3, 2022 Executive Vice President, Global R&D and Chief Medical Officer